type here...
type here...
START FREE TRIAL

M&A

Technology & AIM&AHealthcareConsumer & RetailMedia & EntertainmentIndustrials

BioMarin Amicus Acquisition: A $4.8 Billion Bet on Rare Disease Domination

Healthcare Ishan Majumdar -
BioMarin Pharmaceutical (NASDAQ:BMRN) just made its boldest move in years—unveiling a $4.8 billion all-cash acquisition of Amicus Therapeutics. The move, announced in December 2025,...

APi Group CertaSite Acquisition Sparks Investor Debate

Industrials Ishan Majumdar -
In a season crowded with earnings calls, margin debates, and cautious optimism, one headline stood out: APi Group (NYSE:APG) has signed an agreement to...
spot_imgspot_img

Netflix Warner Bros Acquisition Could Change Streaming Forever

M&A Ishan Majumdar -
The streaming wars just got their biggest twist yet. Netflix, already the world’s largest video platform by subscribers, is...

Paramount Warner Bros Merger vs. Netflix Explained!

M&A Ishan Majumdar -
The gloves are off in the media megamerger race. In a bold, attention-grabbing move, Paramount Skydance Corp. has hiked...

Abbott Exact Sciences Acquisition: $21B Cancer Gamble

M&A Ishan Majumdar -
Abbott Laboratories is back in the M&A spotlight. Just days after confirming its plan to buy cancer-screening heavyweight Exact...

Adobe Acquires Semrush: Game-Changer for Marketers?

M&A Ishan Majumdar -
Adobe just made a bold move that could shift the digital marketing landscape—again. Last week, the company announced a...

Johnson & Johnson Halda Acquisition: The $3.05 Billion Gamble!

Healthcare Ishan Majumdar -
Johnson & Johnson just made another big move. The company announced that it will buy Halda Therapeutics for $3.05...

Merck Cidara Acquisition: $9.2B Flu Drug Deal to Replace Keytruda

Healthcare Ishan Majumdar -
Merck isn’t waiting around for Keytruda’s patent clock to run out. On November 14, the pharma giant announced its...
Load more

BioMarin Amicus Acquisition: A $4.8 Billion Bet on Rare Disease Domination

Healthcare Ishan Majumdar -
BioMarin Pharmaceutical (NASDAQ:BMRN) just made its boldest move in years—unveiling a $4.8 billion all-cash acquisition of Amicus Therapeutics. The...

APi Group CertaSite Acquisition Sparks Investor Debate

Industrials Ishan Majumdar -
In a season crowded with earnings calls, margin debates, and cautious optimism, one headline stood out: APi Group (NYSE:APG)...

Netflix Warner Bros Acquisition Could Change Streaming Forever

M&A Ishan Majumdar -
The streaming wars just got their biggest twist yet. Netflix, already the world’s largest video platform by subscribers, is...

Paramount Warner Bros Merger vs. Netflix Explained!

M&A Ishan Majumdar -
The gloves are off in the media megamerger race. In a bold, attention-grabbing move, Paramount Skydance Corp. has hiked...

Abbott Exact Sciences Acquisition: $21B Cancer Gamble

M&A Ishan Majumdar -
Abbott Laboratories is back in the M&A spotlight. Just days after confirming its plan to buy cancer-screening heavyweight Exact...

Adobe Acquires Semrush: Game-Changer for Marketers?

M&A Ishan Majumdar -
Adobe just made a bold move that could shift the digital marketing landscape—again. Last week, the company announced a...

Johnson & Johnson Halda Acquisition: The $3.05 Billion Gamble!

Healthcare Ishan Majumdar -
Johnson & Johnson just made another big move. The company announced that it will buy Halda Therapeutics for $3.05...

Merck Cidara Acquisition: $9.2B Flu Drug Deal to Replace Keytruda

Healthcare Ishan Majumdar -
Merck isn’t waiting around for Keytruda’s patent clock to run out. On November 14, the pharma giant announced its...

Kimberly Clark’s $48.7B Kenvue Deal: A Power Move or an Expensive Mistake?

M&A Ishan Majumdar -
Kimberly-Clark just made the biggest move in its 150-year history, agreeing to acquire Kenvue—the Johnson & Johnson spin-off and...

Paramount & Skydance’s Bold $70 Billion Gamble: Ellison-Backed Bid For Warner Bros. Discovery

M&A Ishan Majumdar -
Paramount Skydance is preparing to launch one of the most ambitious takeover attempts in Hollywood’s history: a majority cash...

Vimeo Gets Bought Out? Here’s What Bending Spoons Might Be After

M&A Ishan Majumdar -
Vimeo Inc. (NASDAQ:VMEO), the once high-flying video hosting platform, is set to be acquired by Bending Spoons in an...

Zepp Health’s Wild.AI Acquisition: Could This Be A Game-Changer For Female Sports Tech?

Consumer & Retail Ishan Majumdar -
Zepp Health, the parent company of the Amazfit brand, is making headlines once again. After achieving its first quarter...
Load more

Baptista Research is a financial research house focused on the U.S. markets. We cover the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms.

Company

Headlines

BioMarin Amicus Acquisition: A $4.8 Billion Bet on Rare Disease Domination

0
BioMarin Pharmaceutical (NASDAQ:BMRN) just made its boldest move in...

Meta Mango Image Video AI Is Coming for Google’s Nano Banana & Adobe!!

0
Meta Platforms (NASDAQ:META) is getting serious about becoming a...

Blue Owl Exit Puts Oracle AI Data Center Funding Strategy in Question

0
Oracle's (NYSE:ORCL) AI ambitions may have been too big,...

How To Read A Stock Research Report: Valuation, Risks & Key Metrics Explained

0
If you have ever opened a professional stock research...

Newsletter

Get important news delivered directly to your inbox and stay connected!

Copyright © 2025 Baptista Research. All rights reserved.